Search Videos and More
News
HER2-Targeted Agents: Not Just for Breast Cancer
With 20% of breast cancers driven by alterations to the HER2 gene, inhibiting the expression of this gene has been an objective of researchers and clinicians for decades, and a number of inhibitory therapies have been developed.
News
Harnessing the Power of Adaptive Radiation Therapy: A One-Year Review from Fox Chase Cancer Center
Over the past year, the Fox Chase Cancer Center Radiation Oncology team led by Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase and the Lewis Katz School of Medicine at Temple University, has boldly moved adaptive radiation therapy into the mainstream, demonstrating its clinical advantages for treating prostate, bladder, liver, pancreas, breast, lung, and head and neck cancers.
News
Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community
Clinical trials are among the most important resources when it comes to effectively treating challenging cases of cancer, but at Fox Chase Cancer Center, these trials encompass much more than just testing new drug candidates that may be more effective alternative treatments.
News
Fox Chase Fellows – Winter 2024
People say you never really leave Fox Chase. Just ask Matt Zibelman, MD, who was a Fox Chase hematology/oncology fellow and now is the GU Service Line Director of Clinical and Translational Research—or his colleague Mark Hallman, MD, PhD, a former Fox Chase Radiation Oncology resident, now serving as the GU Service Line Clinical Director
News
Many Legacies to Carry On
In May 2023, Michael O. Meyers, MD, a surgical oncologist at UNC, was named the James F. and Alice B. Newsome Distinguished Professor.
News
Fox Chase Researcher’s Presentation Highlights Unique Approach to Esophagectomy at American College of Surgeons Clinical Congress
Nosayaba Enofe, MD, presented his experience with a unique minimally invasive hybrid approach to esophagectomy at the American College of Surgeons Clinical Congress.
Symposium
22nd Annual Highlights of the 2023 San Antonio Breast Cancer Symposium
News
Inspiring Residents to Climb Higher
When asked why he chose Fox Chase Cancer Center for his urologic surgery fellowship (2019-2021), Marshall Strother, MD, responds, “I liked the way ‘Fox,’ as he calls Fox Chase, has an exacting, intentional, and deliberate method of training. Hierarchies are flattened there, allowing new surgeons to work and learn with the most experienced on the team.”
News
Celebrate Our Anniversary with Your Vote.
This year, Fox Chase Cancer Center celebrates our 50th anniversary of excellence in cancer care and our 50th year as a National Cancer Institute-designated Comprehensive Cancer Center. This anniversary is a special time to thank our brilliant Fellows and Residents, past and present.
News
National and International Accolades
Meet the bold clinicians and researchers whose work and perseverance push the edge of discovery, and have helped Fox Chase Cancer Center reach our 50th anniversary of excellence in cancer care.
News
Benign Prostatic Hyperplasia
With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted leader in treating all types of urologic conditions.
News
Fox Chase-Temple Urologic Institute: The Next Generation of Urology Care
Our innovative partnership unites the expertise of distinguished institutions within one health system, allowing us to tackle the most challenging genitourinary malignancies as well as complex benign urologic conditions.